Company / SG&A Expense
Becton Dickinson SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$5.3B
FY2025
5-year range
$4.7B / $5.3B
FY2021-FY2025
Trend
+8.7%
vs FY2024
Sector context
#15 of 158
Health Care
What the data says
Among 158 Health Care companies, Becton Dickinson is in the bottom 9% for sg&a expense. SG&A Expense has increased for 3 consecutive years, from $4.7B in FY2022 to $5.3B in FY2025.
Based on SEC 10-K filings.
$5.3B in FY2025 with a 5-year CAGR of +4.8%. Top quartile in the Health Care sector.
Increased from $4.7B to $5.3B over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +3.9%
- 5-Year CAGR
- +4.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 158This company $5.3B Sector average $175.9B
▼
-97.0% below sector average
Key checks
Key Insights
- Becton Dickinson's sg&a expense has grown for 3 consecutive years.
- 5-year CAGR of +4.8%, indicating consistent growth.
- In FY2025, sg&a expense increased 8.7% year-over-year.
- Ranks #15 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.16 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.3B | +8.7% |
| FY2024 | $4.9B | +2.9% |
| FY2023 | $4.7B | +0.2% |
| FY2022 | $4.7B | -0.2% |
| FY2021 | $4.7B | +12.8% |
| FY2020 | $4.2B | -3.4% |
| FY2019 | $4.3B | +7.9% |
| FY2018 | $4.0B | +38.1% |
| FY2017 | $2.9B | -3.2% |
| FY2016 | $3.0B | +17.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026